What peptide microarrays enable
Understanding infectious disease immunity requires more than detecting whether antibodies bind a pathogen. Peptide microarrays reveal exactly where antibodies bind, enabling researchers to identify immunodominant epitopes, track variant recognition, and discover serological biomarkers.
Distinguish acute infection from past exposure and differentiate between related pathogens or serotypes.
Test thousands of peptides covering viral, bacterial, fungal, or parasitic antigens to map antibody responses during infection.
Identify strain-specific versus conserved responses to distinguish closely related pathogens that cross-react in traditional assays.
Map which antibody profiles associate with disease severity, recovery, or chronic infection across patient cohorts.
Analyze antibody profiles across patient cohorts to identify immune patterns associated with infection outcomes.
Detect epitope-level patterns associated with disease severity or recovery.
Confirm epitope-specific signatures hold across demographics, disease stages, and co-infections.
Prioritize epitopes suitable for next-generation serological tests with high specificity and sensitivity.
Assess seroprevalence in communities to understand population-level immunity and infection history.
Detect mutations that disrupt antibody binding.
Map antibody prevalence to assess immunity gaps and guide vaccination strategies.
Fast array design-to-assay turnaround lets you characterize immune responses before established assays exist.
Epitope-level profiling answers questions that shape outbreak response, diagnostic development, and immunity assessment. Here’s how researchers use peptide microarrays to understand pathogen-specific immune responses.
Serological samples can be complex. Your analysis workflow shouldn’t have to be. Infectious disease research often relies on established serological methods to detect antibodies against pathogens. Peptide microarrays complement these approaches by revealing which epitopes antibodies recognize, adding epitope-level resolution to your data.
PEPperCHIP® Peptide Microarrays |
ELISA |
Multiplex Bead Assays (Luminex) |
Protein Microarrays |
Neutralization Assays |
|
|---|---|---|---|---|---|
| Typical question | Which exact epitopes do antibodies recognize? | Are antibodies present against this antigen? | How strong are the antibody responses to multiple antigens? | Which proteins are the antibodies recognizing? | Do antibodies block infection? |
| Resolution | Single amino acid | Single amino acid | Antigen-level | Protein-level | Functional |
| Antigen coverage per run | Complete proteomes (≤45K peptides) | Selected antigens | 10-100 antigens | ≤~20K proteins | Single pathogen strain |
| Sample throughput | Medium - high | High | High | Low - medium | Low (complex, time-intensive) |
| Best for | Epitope mapping, diagnostic discovery, strain comparison | Routine screening, quantification | Multi-pathogen panels, seroprevalence studies | Antigen discovery, protein-interaction profiling | Functional immunity, vaccine efficacy studies |
Specialized capability
Pathogen profiling studies follow a straightforward workflow. Experiments can be performed in your own lab or through our PEPperMAP® service.
PEPperPRINT
You
PEPperPRINT
You
PEPperPRINT
You
PEPperPRINT
You
PEPperPRINT
You
PEPperPRINT
You
PEPperPRINT
You
PEPperPRINT
You
Certainly! The flexibility and high capacity of our platform allows us to fully customize everything from content, to peptide length, to microarray layout. For broad screening, we also have a selection of pre-designed peptide microarrays that cover different pathogens which you can browse here.